Immunotherapy in Triple-Negative Breast Cancer

Abstract Currently, immunotherapy has led to a paradigmatic shift in the treatment of many cancer types, including triple-negative breast cancer. Immunotherapy increases the efficacy of the immune system in treating cancer, with a durable effect due to immunologic memory. The PD-1 inhibitor, pembrol...

Full description

Bibliographic Details
Published in:Oncology and Therapy
Main Authors: Elisa Tiberi, Alessandro Parisi, Mirco Pistelli, Agnese Savini, Federica Galassi, Chiara Reschini, Debora Quintavalle, Riccardo Napoleoni, Carlo Ferrari, Rossana Berardi
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-05-01
Subjects:
Triple-negative breast cancer
Immunotherapy
Early breast cancer
Metastatic breast cancer
Online Access:https://doi.org/10.1007/s40487-025-00346-2

Internet

https://doi.org/10.1007/s40487-025-00346-2

Similar Items